After i.v. administration, the distribution and elimination of many drugs may be simulated by a compartmental mathematical model. The analogue can be used to construct such models in electrical terms. When programmed with an appropriate model, the analogue can be used in a wide range of predictive studies. The application of the analogue is illustrated by analysis of serial plasma concentrations of fentanyl and pancuronium.
Detailed understanding of the pharmacokinetics of drugs given by the i.v. route is fundamental to modern anaesthesia. We describe the development of an electrical analogue which simplifies the analysis of pharmacokinetic data and allows extrapolative studies to be performed (Hull and McLeod, 1975) .
After i.v. injection, the plasma concentrations of many drugs increase rapidly to a peak and then decay along a single or multi-exponential curve. This behaviour has been compared (Riggs, 1963) with that of compartmental mathematical models, which have formed the basis of most modern pharmacokinetic analysis (Jusko and Gibaldi, 1972; Klotz et al., 1974) .
The compartmental model assumes that the drug is dispersed immediately into a volume of distribution (Vj)), having an initial concentration (C o ) (Riegelman, Loo and Rowland, 1968) .
Where D = dose given,
The drug is eliminated from this compartment along a concentration gradient, so that in this simple, first-order model, C, = C 0 .e-» (2) where C, = concentration of drug at time t K = elimination rate constant (also represented by K Eli in some equations below) e = 2.718
If (2) This one-compartment model can be expressed diagrammatically, as in figure 2. (The distribution volume is, of course, derived from dose and concentration, so that it is a conceptual rather than an anatomical volume.) Indeed, because of protein binding, the distribution volume for some drugs (such as pethidine) may appear to exceed 300 litre (Klotz et al., 1974 The model parameters can be derived from the second-order equation (4) by a series of formulae (Portman, 1970) : 4) ; a process notoriously liable to error. Digital computer programs have, of course, been constructed for curve-fitting routines, using successive approximation and least squares error analysis, but such techniques are limited to workers with suitable computing facilities. Analogue computer techniques have also been employed, but have generally approached the problem as solvers of differential equations rather than simulators of drug movement (Brownell, Caviacchi and Perry, 1953; Fish, 1958; Fleischli and Cohen, 1966) . A more rational approach uses a passive network of resistors and capacitors to simulate the compartmental structure of the model (Higinbotham et al., 1962; Mapleson, 1963) . Such passive networks are uniquely suited for this purpose, as they can generate exponential functions with great accuracy and minimal cost. Our analogue is similar in concept, but extends the principle further by the use of complex active circuits.
The system consists of four parts (fig. 5):
(1) X-Y Recorder. This is automatically controlled, and plots both input data and results. (2) Data Input Matrix. Into this device are fed the serial plasma concentrations of the drug following a single i.v. injection. They are then stored as electrical voltages until required. (3) Timer Programmer. This is simply a pulse generator, which can be programmed to give "doses" of drug to the model whenever required. (4) The Analogue. This consists of a calibrated network of capacitors and resistors to represent distribution volumes and rate constants. The concentration of drug in any compartment may be plotted continuously by the recorder, during any desired "dosage" regime. A built-in logarithmic converter enables data from both the input matrix and the analogue network to be plotted on semi-logarithmic co-ordinates whenever required.
The system is operated in two distinct modes: (1) Given a set of plasma concentrations, a compartmental model is derived which describes them best. (Up to three compartments.) (2) Given a model, the analogue may be used to predict the effects of any desired administrative regime, and to investigate the effects of changes in model parameters, such as elimination rate.
In the following sections, the analogue will be described in greater detail, with an account of the basic calibration procedure. The operation of the analogue will be illustrated by detailed analysis of two sets of clinical data.
PRINCIPLE OF OPERATION
If an integrator is connected with a parallel resistor R as in figure 6 , and charged to voltage V o , the output will decay exponentially according to
which is analogous to (2). Moreover, the rate constant K may be denned further:
Charging the capacitor with Q coulomb increases the voltage to Q/C volts. Since charge Q = It (ampere Since coulombs and farads are very large quantities, scaling factors are applied, so that 1 litre is generally equivalent to 2.5 \iF.
This arrangement corresponds to the one-compartment model. It can be extended readily by the addition of further capacitors and resistors to twoor three-compartment versions (figs. 7, 8 and 9) .
The analogue model is operated in the following manner. The plasma drug concentrations and times are programmed into an array of simple potentiometers, one pair of co-ordinates at a time, so that the plotter pen reads each correctly. The control system can subsequently re-plot these co-ordinates as small circles (1 mm) at the start of each print cycle. After suitable scaling (see below), a "dose" of drug is entered, and the plotter records automatically the "plasma" (Compartment A) concentration over any required period (normally 6 h). The concentration in other compartments may be followed also, in order that multicompartmental plots may be constructed. By adjusting the values of C v C 2 , R v R& etc., a series of curves are drawn so as to approach the data points by successive approximation, until a best "fit" is achieved. The true parameters of the model can now be derived readily. Volumes are read directly from the decimal selector switches on the panel. Resistor values are read directly and, after multiplication with a scaling factor, are used to calculate the rate constants. If scaling factor = F, then:
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A TTL logical control system makes the operation of the analogue very simple, as all sequential switching operations are fully automatic (figs. 10 and 11). When closed by the programmer, Reed Relay RR1 injects constant current into the integrator. RR2 (through a small resistor) resets C x and RR4 resets C 2 , on command from the sequence logic. RR3 isolates the whole network (apart from C x ) from the integrator, during dose insertion plus an additional period of 100 ms at the beginning of a sequence. This ensures that the whole of the dose is inserted before any discharge can occur, and that the plotter pen is at C o before decay starts. This does not apply, of course, to subsequent increments given during the run. S x selects between one-and two-compartment models and S 2 removes the elimination pathway for calibrating purposes. S 3 allows the buffer amplifier to read drug concentration in Compartment A or B, as well as the preset values in the program matrix.
(Similar facilities are, of course, extended to Compartment C but are not drawn in figure 11 , to avoid confusion.) The logic control also controls pen lift and lowering and resets all capacitors, including the time base, at the end of each run. A new run cannot be started while a residual charge remains in any compartment.
A separate TTL sequence controller draws X and Y axes, and operates the co-ordinate plotting routine before each run, as required.
A variable threshold comparator is connected to the Y axis plotter input. When set to a particular drug concentration, this device may be programmed to initiate a new dose of drug whenever the "plasma" concentration decreases to this level. This facility enables optimal dose regimes for any desired "plasma concentration" to be established readily.
The log/lin selector (S 4 ) allows the entire operation to proceed in either mode, including the pre-plotted data co-ordinates.
S 5 ganged with S 3 allows the plotter to "see" either the data co-ordinates or the integrator and time base.
SCALING AND OPERATION OF THE ANALOGUE MODEL
The analogue, being a direct simulation of drug movement, is very simple to scale.
(1) The vertical C, (drug concentration) scale of the plotter output is decided upon. Units are chosen so that data lie between 6.0 and 403.5 (corresponding to 1.8 and 6.0 respectively on the natural logarithm (In) scale. This is the operating range of the logarithm converter.) These scale units may be pLgml-1 cm~1; ngml~1cm~1, or even 3.6 x 10-' g ml-icm-1 . (2) The integrator control is set to "volume", so that RR2 and RR3 are opened, leaving only C 1 in circuit. Any charge placed on C ± in this mode will be held until reset. C x (Volume A) is set to 10 litre (25 [J.F). (3) A current pulse (50 ms) is now applied to the input from the Digitimer 4030. From the C t value produced at the output, and knowing the volume, the dose equivalent of the pulse is easily determined (for example, 10 [ig ml" 1 reading means that 50 ms oc 100 mg). (4) The time base is normally set at 1200 times faster than real time (1 h of data plots on 6 cm of paper in 3 s).
On this basis, the rate constant (K) can be calculated for any RC combination.
Since iC = (RxC)-1 s (R ohms, C farads), 1 litre = 2.5 jxF and t = 1200-1 real time, the model rate constant (K) is: 
(Referring to equations (12) and (17), "F" is seen to be 1200 in this case.) (5) The plasma concentrations may now be programmed into the matrix, using the pen deflection as an indicator. (6) The data co-ordinates are plotted automatically and the curve fitted by successive approximation, as described above. Both linear and logarithmic print-outs are used for this purpose, to ensure maximum accuracy. (7) Volume and rate constants may now be derived, as described previously.
APPLICATIONS OF THE PHARMACOKINETIC ANALOGUE

Example 1: pancuronium bromide
An anaesthetized subject was given pancuronium bromide 4 mg i.v. and serial venous samples were collected. Plasma pancuronium concentrations were estimated by the Rose Bengal technique (Kersten, Meijer and Agoston, 1973) . The values obtained are listed in table I, columns 1 and 2.
All values of fAg/ml" 1 are multiplied by 100 to bring the scale into the range of the logarithmic converter. Each unit is now 1 g ml" 1 x 10~8. Each scaled value is then converted to its natural logarithm in column 4. A test "dose" of 100 ms into V A = 10 litre results in a concentration reading (linear) of 48.2. Scaled back to (jig ml-1 , this is 0.482 (Ag ml" 1 , or 4.82 mg in 10 litre. A 4-mg dose is therefore represented by 82.9 ms. The scaled plasma concentrations (column 3) are entered and plotted as described above. They appear to follow a biexponential course ( fig. 12 ) and a twocompartment model is found to give a satisfactory solution. The points and solution are re-plotted on linear ordinates as a check procedure ( fig. 13 ). The model can now be used to predict the effects of a wide variety of dose regimes on the subject studied, in addition to investigating the effect of variation of model parameters.
Extrapolation. It has been shown by single-dose studies (McLeod, Watson and Rawlins, 1976) K Eh was then reduced to 0.372 h" 1 , and the procedure was repeated (line B). The differences in drug concentrations are striking, the more so as the total dose increases. After the last increment, recovery of the model with reduced K EIj lags behind the "normal" model by approximately 3 h.
Example 2: fentanyl citrate
A 52-year-old female subject received tritiated fentanyl 50 \Lg i.v. Serial venous samples were collected and the plasma fentanyl concentrations were estimated by toluene extraction and liquid scintillation. The values obtained are shown in table II, columns 1 and 2. In order that the values were within the range of the analogue, they were scaled by a multiplier of 70. Column 3 lists the scaled values (ng ml" 1 x 70), with the corresponding natural logarithms in column 4. From the standard "test dose" procedure, it can be calculated that a "dose" of 71.4 ms is equivalent to 50 fig if we assume that 0.25 [xF represents 1 litre. The points are now plotted on semi-log e ordinates, and an attempt is made to fit the curve with a twocompartment model. This is obviously impossible, as the relatively smooth curve is dissimilar to the second-order decay in shape ( fig. 15) . FIG. 15 . Measured plasma concentrations of fentanyl citrate. Attempted two-compartment "fit" to the data, which is obviously impossible.
A third compartment is added (type 1) and a satisfactory fit is obtained easily (fig. 16) Extrapolation. In anaesthetic practice, regular increments of fentanyl are commonly given after an initial loading dose. Using the electrical analogue, it is possible to predict the plasma concentrations which might follow such a regime. It is possible also to determine the influence of the loading dose on subsequent plasma concentrations and to determine the degree to which cumulation might occur if increments were continued for extended periods. (Such a study on a three-compartment model could be performed by mathematical treatment alone. The mathematics of three-compartment multi-dose kinetics are, however, extremely arduous, especially if the doses and intervals are varied.)
The dose programmer is set to deliver 25-fig increments every 10 min. Figure 18 plots the result on linear ordinates. Peak drug concentrations in Compartment A are seen to increase steadily during the 5-h period. The drug concentration in Compartment C is still increasing at 5 h, suggesting that the system is not nearing equilibrium. Figure 19 shows a 165-^g loading dose given before commencing the increments. A high initial peak is followed by a constant peak drug concentration. At the end of 5 h, however, the system behaves much the same as with increments only (fig. 18 ). A three-compartment model under incremental conditions will reach a constant peak value in Compartment A when the value in Compartment C becomes constant. Figure 20 represents a further extrapolation of figures 17 and 18, with the time base extended to 50 h, to determine equilibration time.
The pre-loaded model approaches equilibrium in Compartment C more rapidly than do increments alone but reaches the same final concentration in approximately 30 h. On stopping dosage, the decay of drug from Compartment C is very slow, so that an extended duration of action might be expected. On the basis of this study, increments of fentanyl might be expected to show marked cumulative characteristics, for at least 10 h in the subject represented by the model, resulting in prolonged elevation of plasma concentrations.
DISCUSSION
The above cases are not, of course, intended to provide new information on the pharmacokinetics of pancuronium or fentanyl. Indeed the pancuronium example is taken from previously published work (McLeod, Watson and Rawlins, 1976) . The fentanyl example is taken from work in progress. They are included to provide worked examples of the use of the analogue, in both analytical and extrapolative modes. Studies to test the predictive validity of compartmental models for pancuronium and fentanyl are at an advanced stage, and will be presented in due course.
CONCLUSION
The analogue is intended to be useful, rather than to represent technical or conceptual innovation. It is designed so that measured plasma concentrations of drugs can be converted readily to model parameters, which enable predictive studies to be performed. In the cases of both fentanyl and pancuronium, our knowledge of detailed pharmacokinetics is sparse, so that such predictive experiments are likely to be of clinical significance, at least until more measured data are available.
The analogue does not, and does not attempt to, relate compartmental behaviour to levels of pharmacological activity. The inter-relationships between receptor and whole-body pharmacokinetics are complex, and more information is required before valid models can be constructed. rechner kann zur Konstruktion eines solchen Modells in elektrischen Bezugswerten verwendet werden. Nach Programmierung mit einem entsprechendem Modell kann der Analogrechner fiir eine grosse Auswahl von VorhersageStudien venyendet werden. Sine Anwendung wird gezeigt durch die Analyse von seriellen Plasmakonzentrationen von Fentanyl vind Pancuronium.
ANALISIS FARMACOCINETICO USANDO UN ANALOGO ELECTRICO
SUMAMO
Tras la administration i.v., la distribution y elimination de muchos farmacos pueden ser simuladas mediante un modelo matematico compartamental. El analogo puede usarse para construir tales modelos en terminos electricos. Cuando se programa con un modelo apropiado, el analogo puede utilizarse en una amplia gama de estudios predictivos. La aplicacion del analogo es ilustrada mediante un analisis de concentraciones plasmaticas seriadas de fentanil y pancuronio.
